• Multimodal Targeting of Pancreatic Fibrosis via MFGE8-ANXA1-

  2026-06-30

  The reference study pioneers a multimodal approach for attenuating pancreatic fibrosis in chronic pancreatitis, leveraging umbilical cord-derived mesenchymal stem cells (UCMSCs), their extracellular vesicles, and a novel rhMFGE8 nanoparticle delivery system. Mechanistic insights into the MFGE8-dependent ANXA1-SMAD2/3 signaling axis provide a foundation for future antifibrotic therapies.

• Dual Glutamate Receptor Blockade Reduces Soman Neurotoxicity

  2026-06-30

  The reference study demonstrates that the dual AMPA/NMDA receptor antagonist IEM-1925 provides superior protection against soman-induced status epilepticus, neurodegeneration, and cognitive impairment in rats. This work highlights the therapeutic potential of targeting glutamate receptor-mediated excitotoxicity in organophosphorus nerve agent (OPNA) poisoning, with implications for advancing neuroprotection research.

• RESTRICT-seq Reveals Novel Epigenetic Dependencies in SCC Re

  2026-06-29

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening platform that uncovers critical epigenetic regulators underlying squamous cell carcinoma (SCC) resistance. These findings highlight actionable vulnerabilities in epigenetic pathways and provide a robust framework for dissecting oncogene-induced senescence and therapeutic response.

• SLC25A1-Driven Senescence and Cisplatin Resistance in HNSCC

  2026-06-29

  This article examines how upregulation of SLC25A1 drives cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) through H3K27ac-mediated cellular senescence. The study provides mechanistic insights into metabolic-epigenetic crosstalk and highlights SLC25A1 as both a predictive biomarker and a potential therapeutic target in chemoresistant HNSCC.

• Neomycin Sulfate: Protocols and Innovations in Molecular Bio

  2026-06-28

  Neomycin sulfate stands out as a mechanistically versatile aminoglycoside antibiotic, bridging nucleic acid structural biology and ion channel research. Explore applied protocols, advanced troubleshooting, and direct workflow enhancements that differentiate its use for RNA/DNA interaction studies and beyond.

• Hyaluronic Acid Sodium Salt in siRNA Delivery & ECM Modeling

  2026-06-27

  Hyaluronic acid sodium salt is redefining both extracellular matrix modeling and targeted siRNA nanoparticle delivery, bridging structural and immunomodulatory research needs. Recent breakthroughs highlight its role in directing immune cell fate and enhancing assay reliability across infectious disease and cell biology applications.

• Carboxylesterase Disrupts Amplex Red H2O2 Assays: Methodolog

  2026-06-26

  This study demonstrates that carboxylesterase enzymes can directly convert Amplex Red to resorufin, independently of hydrogen peroxide and peroxidase, challenging the established specificity of a widely used mitochondrial H2O2 detection method. These findings underscore the need for careful assay validation and offer practical corrections to improve the reliability of reactive oxygen species measurements in biological samples.

• Optimizing PI3K/AKT Studies with 740 Y-P: Technical Guidance

  2026-06-26

  740 Y-P is a potent, cell-permeable PI 3-kinase activator for precise modulation of the PI3K/AKT pathway in cellular and biochemical assays. It addresses research needs in vesicular trafficking, neuronal survival, and apoptosis studies, but is not intended for therapeutic or in vivo applications. Researchers should follow protocol and solubility guidelines to maximize reproducibility and avoid solubility-related workflow issues.

• Cefazedone (Refosporen): Optimized Workflows for Antibacteri

  2026-06-25

  Cefazedone (Refosporen) delivers robust, β-lactamase-resistant activity across Gram-positive and Gram-negative pathogens, enabling highly reproducible antibacterial testing. This guide translates recent chromatographic and pharmacokinetic advances into actionable protocols, troubleshooting strategies, and comparative insights for experimental and translational researchers.

• WSP-5: Deepening the Science of H2S Imaging in Cardiometabol

  2026-06-25

  Explore how WSP-5 (Washington State Probe-5) advances sensitive detection of hydrogen sulfide in live-cell imaging, with a focus on cardiometabolic disease models and mechanistic assay choices. This article offers a unique, evidence-driven analysis distinct from standard workflow guides.

• Erastin as a Ferroptosis Inducer: Applied Workflows and Opti

  2026-06-24

  Erastin empowers cancer biology and ferroptosis research with precision, enabling selective induction of iron-dependent non-apoptotic cell death in RAS/BRAF-mutant models. This guide translates cutting-edge mechanistic findings and in vitro protocols into actionable workflows, troubleshooting tips, and advanced applications for oxidative stress and cell death assays.

• N1-Methyl-Pseudouridine-5'-Triphosphate in mRNA Therapeutics

  2026-06-23

  N1-Methyl-Pseudouridine-5'-Triphosphate empowers researchers to create highly stable, translationally efficient mRNA for advanced therapeutic and vaccine applications. This article details optimized workflows, troubleshooting strategies, and cutting-edge use-cases, including localized mRNA delivery for tumor suppressor replacement in bladder cancer.

• Rotigotine's Modulation of Bladder Function in PD Rat Models

  2026-06-23

  This study elucidates the mechanistic effects of rotigotine, a dopamine D1/D2-like receptor agonist, on lower urinary tract function in a rat model of Parkinson’s disease. By characterizing dose-dependent impacts on micturition reflexes, the research provides insight into both motor and non-motor symptom modulation, with implications for translational approaches targeting autonomic dysfunction in PD.

• APOC1 and Cyclopamine Synergy in Papillary Thyroid Carcinoma

  2026-06-22

  This study identifies Apolipoprotein C1 (APOC1) as a driver of papillary thyroid carcinoma (PTC) progression and immune evasion. It demonstrates that cyclopamine, a Hedgehog signaling inhibitor, synergistically enhances apoptosis and suppresses tumor proliferation in APOC1-driven PTC, providing a rationale for targeted therapy approaches.

• Optimizing Cell-Based Assays with Cy5.5 NHS Ester (Non-Sulfo

  2026-06-22

  This article explores practical laboratory scenarios where Cy5.5 NHS ester (non-sulfonated) (SKU A8103) addresses key challenges in biomolecule labeling and fluorescence imaging. Using validated evidence and workflow insights, it guides researchers in cell viability and cytotoxicity assays toward reproducible, high-sensitivity results with APExBIO’s advanced near-infrared dye.

408 records 10/28 page Previous Next First page 上5页 678910 下5页 Last page